Developing life-saving medicine takes a lot of time, money and testing. But one company’s artificial intelligence-driven technology provides a way to slash all three while saving the lives of more humans and animals.
VeriSIM Life has developed “digital twins” of various human body types and different animals and uses machine intelligence to test how pharmaceuticals would impact real-life subjects before even going to clinical
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.
Login if you have purchased